Markets:

Overview

News

Currencies

International

Treasuries

Mirati Therapeutics, Inc. - Common Stock (NQ:MRTX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 22, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Mirati Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 08, 2023

Via Benzinga

Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs ↗

March 10, 2023

New branded medicines are coming to market with ever-higher price tags as soon as the first day. Amgen Inc's (NASDAQ: AMGN) lung cancer treatment, Lumakras, carried a hefty price tag of $17,900 per...

Via Benzinga

Why Shares of Zai Lab Soared This Week ↗

January 05, 2023

A strong phase-3 clinical trial boosted investors' hopes for the Chinese biotech company.

Via The Motley Fool

Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors ↗

December 27, 2022

Biopharma stocks were not immune to the broader market downturn seen for much of 2022.

Via Benzinga

SVB Leerink Maintains Outperform Rating for Mirati Therapeutics: Here's What You Need To Know ↗

December 14, 2022

Via Benzinga

Why Mirati Therapeutics Shares Are Nosediving ↗

December 09, 2022

Mirati Therapeutics Inc (NASDAQ: MRTX) shares are trading lower by 4.90% to $41.70 after Citigroup downgraded the stock from Buy to Neutral.

Via Benzinga

BMO Capital Downgrades Mirati Therapeutics: Here's What You Need To Know ↗

December 08, 2022

Via Benzinga

SKLZ Stock Alert: Will Skillz Shares Get Delisted? ↗

December 22, 2022

Skillz (SKLZ) stock is worth checking on today as the company received a delisting notice from the New York Stock Exchange.

Via InvestorPlace

Why Are Chinese EV Stocks NIO, XPEV, LI on Watch Today? ↗

December 22, 2022

Chinese electric vehicle (EV) stocks are a chief concern among investors today as these shares see mixed trading on Thursday!

Via InvestorPlace

Why Is ProQR (PRQR) Stock Up 83% Today? ↗

December 22, 2022

ProQR (PRQR) stock is rising on Thursday thanks to an expanded licensing and collaboration agreement with Eli Lilly (LLY).

Via InvestorPlace

Why Is Mirati Therapeutics (MRTX) Stock Up Today? ↗

December 22, 2022

Mirati Therapeutics (MRTX) stock is rising on Thursday as investors react to a special designation from the FDA for adagrasib.

Via InvestorPlace

5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More ↗

December 15, 2022

The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies.

Via Benzinga

What 10 Analyst Ratings Have To Say About Mirati Therapeutics ↗

December 08, 2022

Via Benzinga

Where Mirati Therapeutics Stands With Analysts ↗

December 08, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗

December 14, 2022

Via Benzinga

Tesla To $235? Here Are 10 Other Price Target Changes For Wednesday ↗

December 14, 2022

Goldman Sachs cut Tesla, Inc. (NASDAQ: TSLA) price target from $305 to $235. Goldman Sachs analyst Mark Delaney maintained a Buy rating on the stock. Tesla shares fell 0.4% to $160.35 in pre-market...

Via Benzinga

Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket ↗

December 13, 2022

Gainers Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.

Via Benzinga

Another Competitor For Amgen As FDA Approves Mirati Therapeutics' KRAS Inhibitor For Lung Cancer Setting ↗

December 13, 2022

Via Benzinga

Pinterest, Oracle And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

December 13, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. ACM Research, Inc. (NASDAQ: ACMR) shares jumped 25.9% to $10.98 in...

Via Benzinga

Nasdaq, S&P 500 Futures Soar Amid Optimistic Expectations Concerning Nov. Inflation: Oracle, Tesla, Pinterest Among Early Movers ↗

December 13, 2022

The index futures point to a modestly higher opening for the market on Tuesday, although the November consumer price inflation due ahead of the open could sway sentiment either way depending on how the...

Via Benzinga

Mirati Wins FDA Approval For Amgen-Rivaling Cancer Drug As Wild Stock Swing Continues ↗

December 12, 2022

FDA action on its KRAS-blocking drug could help recently downtrodden Mirati.

Via Investor's Business Daily

Why Mirati Therapeutics Stock Lost Half Its Value In Just Three Days ↗

December 08, 2022

The company is still planning a Phase 3 study in non-small cell lung cancer.

Via Investor's Business Daily

Why Mirati Therapeutics Shares Are Getting Hammered Again Today ↗

December 08, 2022

Mirati Therapeutics Inc (NASDAQ: MRTX) shares are trading lower by 12.18% to $43.55 during Thursday's session after multiple analysts downgraded their ratings on the stock and lowered their price...

Via Benzinga

Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

December 08, 2022

Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split.

Via Benzinga

Chefs' Warehouse, Chart Industries And Some Other Big Stocks Moving Lower On Thursday ↗

December 08, 2022

U.S. stocks traded higher, with the Dow Jones jumping over 200 points on Thursday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday ↗

December 08, 2022

Via Benzinga

Why Shares of Mirati Therapeutics Fell Wednesday ↗

December 07, 2022

The company presented phase 2 data from its non-small cell lung cancer therapy.

Via The Motley Fool

Why Mirati Therapeutics Stock Is Trading Sharply Lower Today ↗

December 07, 2022

Mirati Therapeutics Inc (NASDAQ: MRTX) shares are trading lower by 29.32% to $50.55 on continued weakness after the company announced late-breaking results

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 07, 2022

Via Benzinga

Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session ↗

December 07, 2022

Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.